Ana B. Herrero

1.4k total citations
42 papers, 1.1k citations indexed

About

Ana B. Herrero is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ana B. Herrero has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Hematology. Recurrent topics in Ana B. Herrero's work include DNA Repair Mechanisms (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Fungal and yeast genetics research (6 papers). Ana B. Herrero is often cited by papers focused on DNA Repair Mechanisms (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Fungal and yeast genetics research (6 papers). Ana B. Herrero collaborates with scholars based in Spain, United States and Poland. Ana B. Herrero's co-authors include Norma C. Gutiérrez, Sergio Moreno, Federico Gago, Esther Marco, Cristina Martı́n-Castellanos, Jesús F. San Miguel, Ángel Domínguez, Irena Misiewicz-Krzemińska, Patryk Krzemiński and Claudia Abeijón and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Ana B. Herrero

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana B. Herrero Spain	21	729	229	142	139	133	42	1.1k
Ramesh B. Batchu United States	25	1.0k 1.4×	446 1.9×	199 1.4×	212 1.5×	137 1.0×	55	1.7k
Alessandro Natoni Ireland	18	701 1.0×	269 1.2×	90 0.6×	183 1.3×	64 0.5×	43	1.1k
Markus M. Weck Germany	18	529 0.7×	282 1.2×	94 0.7×	189 1.4×	173 1.3×	18	1.4k
Chen Bai China	15	311 0.4×	288 1.3×	64 0.5×	88 0.6×	113 0.8×	33	802
Richard R. Gontarek United States	18	852 1.2×	254 1.1×	117 0.8×	46 0.3×	108 0.8×	25	1.3k
Bing Zheng China	21	364 0.5×	343 1.5×	75 0.5×	98 0.7×	71 0.5×	51	1.1k
Zahra Payandeh Iran	22	696 1.0×	262 1.1×	250 1.8×	58 0.4×	62 0.5×	56	1.2k
Xueyan Xi China	16	418 0.6×	225 1.0×	101 0.7×	110 0.8×	196 1.5×	49	1.2k
Mayuko Yamamoto Japan	21	518 0.7×	278 1.2×	120 0.8×	65 0.5×	315 2.4×	69	1.4k

Countries citing papers authored by Ana B. Herrero

Since Specialization

Citations

This map shows the geographic impact of Ana B. Herrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana B. Herrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana B. Herrero more than expected).

Fields of papers citing papers by Ana B. Herrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana B. Herrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana B. Herrero. The network helps show where Ana B. Herrero may publish in the future.

Co-authorship network of co-authors of Ana B. Herrero

This figure shows the co-authorship network connecting the top 25 collaborators of Ana B. Herrero. A scholar is included among the top collaborators of Ana B. Herrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana B. Herrero. Ana B. Herrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quijada‐Álamo, Miguel, Ana B. Herrero, Julio Dávila, et al.. (2025). SAMHD1 dysfunction impairs DNA damage response and increases sensitivity to PARP inhibition in chronic lymphocytic leukemia. Scientific Reports. 15(1). 10446–10446.

Bueno‐Martínez, Elena, et al.. (2024). Chloroquine-induced DNA damage synergizes with DNA repair inhibitors causing cancer cell death. Frontiers in Oncology. 14. 1390518–1390518. 8 indexed citations

Herrero, Ana B., et al.. (2024). TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors. Scientific Reports. 14(1). 8797–8797. 2 indexed citations

Carbonell, Cristina, et al.. (2023). Autophagy, Oxidative Stress, and Alcoholic Liver Disease: A Systematic Review and Potential Clinical Applications. Antioxidants. 12(7). 1425–1425. 34 indexed citations

González‐Sarmiento, Rogelio, et al.. (2023). DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. Cancers. 15(2). 448–448. 16 indexed citations

San‐Segundo, Laura, et al.. (2022). Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity. International Journal of Molecular Sciences. 23(14). 7518–7518. 8 indexed citations

Quwaider, Dalia, Luís A. Corchete, Jesús María Hernández-Sánchez, et al.. (2022). RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation. Experimental Hematology and Oncology. 11(1). 18–18. 11 indexed citations

Quijada‐Álamo, Miguel, María Hernández‐Sánchez, Ana B. Herrero, et al.. (2021). Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 11(2). e304–e304. 11 indexed citations

Herrero, Ana B., Dalia Quwaider, Luís A. Corchete, et al.. (2020). FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma. Journal of Cellular and Molecular Medicine. 24(7). 4171–4182. 29 indexed citations

10.

Quijada‐Álamo, Miguel, María Hernández‐Sánchez, Ana E. Rodríguez‐Vicente, et al.. (2020). CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition. Leukemia. 34(6). 1599–1612. 25 indexed citations

11.

Herrero, Ana B. & Norma C. Gutiérrez. (2017). Targeting Ongoing DNA Damage in Multiple Myeloma: Effects of DNA Damage Response Inhibitors on Plasma Cell Survival. Frontiers in Oncology. 7. 98–98. 41 indexed citations

12.

Herrero, Ana B., Antonio García-Gómez, Mercedes Garayoa, et al.. (2016). Effects of IL-8 Up-Regulation on Cell Survival and Osteoclastogenesis in Multiple Myeloma. American Journal Of Pathology. 186(8). 2171–2182. 35 indexed citations

13.

Herrero, Ana B., Laura San‐Segundo, Susana Hernández-García, et al.. (2015). The Hybrid Molecule, Edo-S101, Impairs Double Strand Breaks Repair in Multiple Myeloma and Synergizes with Bortezomib and Dexamethasone. Blood. 126(23). 5354–5354. 1 indexed citations

14.

Santos-Pereira, José M., Ana B. Herrero, Sergio Moreno, & Andrés Aguilera. (2014). Npl3, a new link between RNA-binding proteins and the maintenance of genome integrity. Cell Cycle. 13(10). 1524–1529. 8 indexed citations

15.

Herrero, Ana B. & Sergio Moreno. (2011). Lsm1 promotes genomic stability by controlling histone mRNA decay. The EMBO Journal. 30(10). 2008–2018. 47 indexed citations

16.

Ferreira, Laura, et al.. (2010). Identificación bacteriana mediante espectrometría de masas matrix-assisted laser desorption ionization time-of-flight. Comparación con la metodología habitual en los laboratorios de Microbiología Clínica. Enfermedades Infecciosas y Microbiología Clínica. 28(8). 492–497. 34 indexed citations

17.

Herrero, Ana B., Alma M. Astudillo, Marı́a A. Balboa, et al.. (2008). Levels of SCS7/FA2H -Mediated Fatty Acid 2-Hydroxylation Determine the Sensitivity of Cells to Antitumor PM02734. Cancer Research. 68(23). 9779–9787. 45 indexed citations

18.

Herrero, Ana B., Javier Botet, Carmen Cuevas, Federico Gago, & Sergio Moreno. (2007). Genome-wide screen reveals antitumor Zalypsis® as a strong inducer of DNA double strand breaks. Cancer Research. 67. 5733–5733. 4 indexed citations

19.

Herrero, Ana B., Cristina Martı́n-Castellanos, Esther Marco, Federico Gago, & Sergio Moreno. (2006). Cross-Talk between Nucleotide Excision and Homologous Recombination DNA Repair Pathways in the Mechanism of Action of Antitumor Trabectedin. Cancer Research. 66(16). 8155–8162. 134 indexed citations

20.

Atienza, Juan Carlos, Rafael A. Martínez‐Díaz, José Antonio Escario, et al.. (1992). Activity Assays of Thiadiazine Derivatives on <i>Trichomonas vaginalis </i>and Amastigote Forms of <i>Trypanosoma cruzi</i>. Chemotherapy. 38(6). 441–446. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact